Perimeter Medical Imaging AI develops real-time optical coherence tomography imaging systems and artificial-intelligence tools for cancer surgery. The company’s Claire OCT+AI device has FDA premarket approval for intraoperative breast cancer margin assessment, while its S-Series OCT platform provides ultra-high-resolution cross-sectional visualization of excised tissue.
Company news commonly covers FDA regulatory milestones, product demonstrations, commercialization activity, clinical and technology updates, operating and financial results, investor conference presentations, and capital-structure actions such as private placements, warrants, and stock-option matters.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Perimeter Medical Imaging AI, Inc. (TSXV: PINK, OTC: PYNKF) announced its participation at the 24th Annual Meeting of the American Society of Breast Surgeons (ASBrS) from April 26-30, 2023, in Boston, MA. The company will host an educational symposium titled "ACT IN THE MOMENT: OCT adds real-time clarity on margin status," featuring prominent breast surgeons who will share their experiences utilizing the Perimeter S-Series Optical Coherence Tomography (OCT) technology. This device provides real-time imaging to assist surgeons during procedures. Perimeter will also offer live demonstrations at Booth #923, showcasing the OCT system's capabilities in visualizing tissue margins at a cellular level. The event underscores Perimeter's commitment to advancing breast cancer surgery technology.
Perimeter Medical Imaging AI, Inc. (OTC: PYNKF) announced the first commercial placement of its Perimeter S-Series OCT system in Utah on April 25, 2023. This FDA-cleared imaging tool, launched in 2021, enhances cancer surgery with real-time, cross-sectional visualization of excised tissues. Dr. Jennifer J. Tittensor, a breast surgeon, will utilize the system to improve margin assessments during surgeries. Perimeter's CEO, Jeremy Sobotta, noted growing interest from surgeons, indicating a positive sales momentum. The company is also advancing its next-generation Perimeter B-Series OCT with ImgAssist AI, supported by a grant of up to $7.4 million from the Cancer Prevention and Research Institute of Texas, highlighting its commitment to innovation in oncological surgery.
Perimeter Medical Imaging AI, Inc. (TSXV: PINK, OTC: PYNKF) announced its participation in the 2023 Bloom Burton & Co. Healthcare Investor Conference on April 25-26, 2023, in Toronto. The company, focused on revolutionizing cancer surgery through advanced imaging technologies, aims to address significant unmet medical needs.
Key details include:
- Company Presentation: April 26, 2023, from 11:00-11:30 AM ET.
- Webcast Link: Register here.
- Presenter: Jeremy Sobotta, CEO.
Perimeter aims to enhance surgical outcomes with its Perimeter S-Series OCT system and investigates the Perimeter B-Series OCT with cutting-edge AI technology, supported by a US$7.4 million grant for clinical trials.